All patientsb
|
Main analysis
|
2005
|
1268
|
4558
|
372
|
199
|
612
|
1.38 (1.19, 1.60)
|
1.27 (1.08, 1.50)
|
All cancer death
|
2005
|
1405
|
4558
|
372
|
244
|
612
|
1.50 (1.31, 1.72)
|
1.37 (1.18, 1.59)
|
All cause death
|
2005
|
1512
|
4558
|
372
|
293
|
612
|
1.63 (1.44, 1.85)
|
1.44 (1.25, 1.65)
|
Use in the year before diagnosis
|
3584
|
2534
|
5693
|
608
|
431
|
573
|
1.32 (1.19, 1.46)
|
1.12 (1.00, 1.26)
|
12 month lag
|
1360
|
712
|
3733
|
234
|
101
|
464
|
1.35 (1.10, 1.67)
|
1.21 (0.96, 1.53)
|
Adenocarcinoma
|
1813
|
1182
|
4015
|
336
|
186
|
561
|
1.33 (1.14, 1.55)
|
1.25 (1.05, 1.49)
|
Additional adjusted for smoking and alcoholc
|
1091
|
780
|
1469
|
206
|
133
|
204
|
1.30 (1.08, 1.56)
|
1.41 (1.13, 1.75)
|
Additional adjusted for BMId
|
1221
|
825
|
1984
|
234
|
135
|
282
|
1.27 (1.06, 1.53)
|
1.26 (1.02, 1.54)
|
All loop diureticse
|
1984
|
1256
|
4514
|
393
|
211
|
656
|
1.35 (1.17, 1.56)
|
1.27 (1.08, 1.50)
|
Additionally adjusted for Stagef
|
270
|
155
|
409
|
43
|
18
|
66
|
0.88 (0.54, 1.44)
|
0.64 (0.35, 1.15)
|
Additionally adjusted for Gradeg
|
1462
|
945
|
3316
|
258
|
134
|
422
|
1.31 (1.09, 1.57)
|
1.26 (1.03, 1.54)
|
Restricted to patients with high grade diagnosish
|
909
|
610
|
1770
|
137
|
81
|
207
|
1.34 (1.06, 1.69)
|
1.37 (1.05, 1.79)
|
Restricted to patients surgically treatedi
|
1029
|
556
|
3198
|
181
|
85
|
385
|
1.64 (1.30, 2.06)
|
1.74 (1.35, 2.23)
|
Restricted to any hypertensive medication usej
|
899
|
563
|
1914
|
283
|
149
|
434
|
1.31 (1.09, 1.57)
|
1.14 (0.93, 1.39)
|
Furosemide vs other antihypertensive medicationk
|
953
|
593
|
2169
|
372
|
199
|
612
|
1.49 (1.27, 1.76)
|
1.31 (1.10, 1.57)
|
Year of diagnosisl: 1998 to 2002
|
507
|
365
|
1496
|
116
|
67
|
232
|
1.52 (1.17, 1.98)
|
1.50 (1.11, 2.02)
|
2003 to 2007
|
719
|
476
|
1779
|
126
|
76
|
211
|
1.60 (1.25, 2.04)
|
1.64 (1.24, 2.15)
|
2008 to 2013
|
779
|
427
|
1283
|
130
|
56
|
169
|
1.07 (0.81, 1.41)
|
1.01 (0.74, 1.38)
|
Restricted to any diagnosis of hypertension/edema/MI/HFm
|
Main analysis
|
906
|
541
|
1978
|
264
|
138
|
440
|
1.36 (1.13, 1.64)
|
1.18 (0.96, 1.46)
|
12 month lag
|
615
|
288
|
1606
|
168
|
75
|
334
|
1.46 (1.13, 1.88)
|
1.22 (0.91, 1.64)
|
Adenocarcinoma
|
813
|
502
|
1721
|
235
|
130
|
393
|
1.33 (1.10, 1.62)
|
1.16 (0.93, 1.44)
|
Additionally adjusted for smoking and alcoholc
|
550
|
368
|
739
|
160
|
101
|
155
|
1.36 (1.09, 1.70)
|
1.36 (1.04, 1.77)
|
Additionally adjusted for BMId
|
630
|
401
|
1013
|
177
|
99
|
223
|
1.24 (0.99, 1.55)
|
1.14 (0.89, 1.47)
|
All loop diureticse
|
890
|
533
|
1949
|
280
|
146
|
470
|
1.34 (1.11, 1.61)
|
1.18 (0.96, 1.45)
|
Additionally adjusted for Stagef
|
129
|
68
|
154
|
33
|
51
|
46
|
1.01 (0.58, 1.78)
|
0.53 (0.24, 1.15)
|
Additionally adjusted for Gradeg
|
659
|
408
|
1435
|
174
|
89
|
274
|
1.31 (1.04, 1.65)
|
1.11 (0.85, 1.45)
|
Year of diagnosisn: 1998 to 2002
|
148
|
108
|
447
|
69
|
35
|
160
|
1.24 (0.85, 1.83)
|
0.95 (0.59, 1.54)
|
2003 to 2007
|
325
|
208
|
809
|
86
|
56
|
141
|
1.65 (1.22, 2.22)
|
1.57 (1.11, 2.23)
|
2008 to 2013
|
433
|
225
|
722
|
109
|
47
|
140
|
1.17 (0.85, 1.60)
|
1.04 (0.72, 1.49)
|